skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.0.1

Summary

Query: Party Name contains all words: TIKKUN LLC
Number of results: 14

Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
92064683
10/25/2016
Tikkun LLC
Mark: ANTIFLU-DES S#:85283070 R#:4790755
Productos Farmaceuticos, S.A. de C.V.
Mark: ANTIFLU-DES S#:86640876
86628410
10/28/2015
Tikkun LLC
Mark: PANTOZOL S#:86628410
GlaxoSmithKline Consumer Healthcare (UK) IP Limited
86092221
03/11/2014
Tikkun LLC
Mark: DESENFRIOL S#:86092221
MENPER DISTRIBUTORS INC.
MSD Consumer Care, Inc.
91218242
09/08/2014
Tikkun LLC
Mark: DESENFRIOL S#:86092221
Mark: DESENFRIOLITO S#:86092233
MSD Consumer Care, Inc.
Mark: DESENFRIOL-D S#:73158265 R#:1101928
Mark: DESENFRIOL S#:74022714 R#:1658634
Mark: DESENFRIOLITO S#:74071977 R#:1719294
92059353
06/10/2014
Tikkun LLC
Mark: HISTIACIL S#:77969642 R#:4432789
Sanofi and Sanofi-Aventis de Mexico SA de CV
Mark: HISTIACIL S#:85951193
86092233
04/01/2014
Tikkun LLC
Mark: DESENFRIOLITO S#:86092233
MSD Consumer Care, Inc.
85261892
08/23/2011
Tikkun Products, LLC
Mark: NO MAS TO MELANOMAS S#:85261892
Johnson & Johnson
91201276
08/22/2011
Tikkun LLC
Mark: BENZAL S#:77970067
Novartis AG
Mark: BANZEL S#:77334627 R#:3613307
77970067
03/24/2011
Tikkun LLC
Mark: BENZAL S#:77970067
Novartis AG
91198472
02/03/2011
Tikkun LLC
Mark: DAXON S#:77967682
Nycomed GmbH
Mark: DAXAS S#:75623026 R#:2762037
Mark: DAXAS S#:77423960 R#:3675126
91196909
10/13/2010
Tikkun LLC
Mark: CAPENT S#:85000693
Laboratorios Columbia, S.A. de C.V.
85000693
09/09/2010
Tikkun LLC
Mark: CAPENT S#:85000693
Laboratorios Columbia, S.A. de C.V.
77968957
09/08/2010
Tikkun LLC
Mark: DILAR S#:77968957
Almirall, S.A.
77967682
09/07/2010
Tikkun LLC
Mark: DAXON S#:77967682
BASF SE
Nycomed GmbH

Results as of 11/28/2020 12:36 PMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY